Assignee
TRUBION PHARMACEUTICALS INC
US·4 granted patents·13 pending applications·266 citations·filing 2000–2010
Top patents by PatentIndex Score
17 records- 0198US7754208B2Binding domain-immunoglobulin fusion proteinsTRUBION PHARMACEUTICALS INC·Filed 2002·Granted Jul 13, 2010·111 cites·8 claims
- 0297US7118751B1DNA vaccines encoding antigen linked to a domain that binds CD40TRUBION PHARMACEUTICALS INC·Filed 2000·Granted Oct 10, 2006·92 cites·14 claims
- 0393US7829084B2Binding constructs and methods for use thereofTRUBION PHARMACEUTICALS INC·Filed 2003·Granted Nov 9, 2010·49 cites·4 claims
- 0488US7846434B2Materials and methods for improved immunoglycoproteinsTRUBION PHARMACEUTICALS INC·Filed 2008·Granted Dec 7, 2010·14 cites·17 claims
- 0565US2009175867A1Single-Chain Multivalent Binding Proteins with Effector FunctionTRUBION PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 0664US2009214539A1B-cell reduction using cd37-specific and cd20-specific binding moleculesTRUBION PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 0762US2009196870A1Binding constructs and methods for use thereofTRUBION PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 0858US2009258005A1Therapeutic compositions and methodsTRUBION PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 0958US2010203052A1Binding domain-immunoglobulin fusion proteinsTRUBION PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 1054US2010150948A1Materials and methods for improved immunoglycoproteinsTRUBION PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1150US2010135900A1Cd37 immunotherapeutic combination therapies and uses thereofTRUBION PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1249US2008279850A1B-Cell Reduction Using CD37-Specific and CD20-Specific Binding MoleculesTRUBION PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1349US2010279932A1Binding constructs and methods for use thereofTRUBION PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 1449US2009148447A1Binding Peptides Having a C-terminally Disposed Specific Binding DomainTRUBION PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1544US2008227958A1Binding proteins comprising immunoglobulin hinge and fc regions having altered fc effector functionsTRUBION PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1643US2008213273A1Single dose use of CD20-specific binding moleculesTRUBION PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1737US2007021591A1Compositions and methods for protein deaggregationTRUBION PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TRUBION PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →